Mg53 protein protects against multiorgan ischemia/reperfusion injury: Present and future

Teng Fei Liu, Jian Kang Zhou, Tuan Jie Huang, Qu Xing, Kang Cheng, Peng Li, Dong Peng Li, Bo Yang, Shan Shan Ma, Fangxia Guan

Research output: Contribution to journalArticle

Abstract

Background: In recent years, with the progress of shock therapy as well as the establishment and promoted application of arterial bypass grafting, thrombolytic therapy, percutaneous transluminal coronary angioplasty, extracorporeal circulation on cardiac surgery, cardiopulmonary resuscitation, limb replantation, and organ transplantation, blood reperfusion in multiple organs after ischemia has been achieved. However, the organs which undergo a period of ischemia appear to have the performance of damage aggravation. Objective: To summarize the research progress of MG53 protein in protecting five organs from ischemia/reperfusion injury, thereby providing reference for further in-depth study. METHODS: A computer-based online search of PubMed, Duxiu Knowledge Search and CNKI databases was performed for relevant literatures puldished between 1986 and 2016. The key words were “MG53, TRIM, Mitsugumin53, ischemic, reperfusion, preconditioning, postconditioning, RISK, membrane damage, Connexin43, KChIP2” in English and “MG53, ischemia/reperfusion” in Chinese. Finally 61 eligible articles were reviewed in accordance with the inclusion and exclusion criteria. Results and Conclusion: As a muscle-specific TRIM family protein, endogenous MG53 is involved in the repair of muscle cytomembrane damage, and the protective effects of ischemic preconditioning and postconditioning. Exogenous recombinant human MG 53 protein not only repairs membrane damage of various muscles and non-muscle cells, but also protects the myocardium, skeletal muscle, brain, lung and kidney from ischemia/reperfusion injury.

Original languageEnglish (US)
Article number2095-4344(2017)20-03248-07
Pages (from-to)3248-3254
Number of pages7
JournalChinese Journal of Tissue Engineering Research
Volume21
Issue number20
DOIs
StatePublished - Jan 1 2017
Externally publishedYes

Fingerprint

Reperfusion Injury
Reperfusion
Muscle
Ischemic Preconditioning
Ischemia
Proteins
Muscles
Ischemic Postconditioning
Convulsive Therapy
Connexin 43
Repair
Coronary Balloon Angioplasty
Extracorporeal Circulation
Membranes
Replantation
Thrombolytic Therapy
Cardiopulmonary Resuscitation
Organ Transplantation
Resuscitation
Transplantation (surgical)

Keywords

  • Blood vessels
  • Ischemia
  • Muscles
  • Organ transplantation
  • Tissue engineering

ASJC Scopus subject areas

  • Orthopedics and Sports Medicine
  • Biomedical Engineering
  • Clinical Biochemistry

Cite this

Liu, T. F., Zhou, J. K., Huang, T. J., Xing, Q., Cheng, K., Li, P., ... Guan, F. (2017). Mg53 protein protects against multiorgan ischemia/reperfusion injury: Present and future. Chinese Journal of Tissue Engineering Research, 21(20), 3248-3254. [2095-4344(2017)20-03248-07]. https://doi.org/10.3969/j.issn.2095-4344.2017.20.021

Mg53 protein protects against multiorgan ischemia/reperfusion injury : Present and future. / Liu, Teng Fei; Zhou, Jian Kang; Huang, Tuan Jie; Xing, Qu; Cheng, Kang; Li, Peng; Li, Dong Peng; Yang, Bo; Ma, Shan Shan; Guan, Fangxia.

In: Chinese Journal of Tissue Engineering Research, Vol. 21, No. 20, 2095-4344(2017)20-03248-07, 01.01.2017, p. 3248-3254.

Research output: Contribution to journalArticle

Liu, TF, Zhou, JK, Huang, TJ, Xing, Q, Cheng, K, Li, P, Li, DP, Yang, B, Ma, SS & Guan, F 2017, 'Mg53 protein protects against multiorgan ischemia/reperfusion injury: Present and future', Chinese Journal of Tissue Engineering Research, vol. 21, no. 20, 2095-4344(2017)20-03248-07, pp. 3248-3254. https://doi.org/10.3969/j.issn.2095-4344.2017.20.021
Liu, Teng Fei ; Zhou, Jian Kang ; Huang, Tuan Jie ; Xing, Qu ; Cheng, Kang ; Li, Peng ; Li, Dong Peng ; Yang, Bo ; Ma, Shan Shan ; Guan, Fangxia. / Mg53 protein protects against multiorgan ischemia/reperfusion injury : Present and future. In: Chinese Journal of Tissue Engineering Research. 2017 ; Vol. 21, No. 20. pp. 3248-3254.
@article{df211ff2e4f74dc48b06f1fe398bbb52,
title = "Mg53 protein protects against multiorgan ischemia/reperfusion injury: Present and future",
abstract = "Background: In recent years, with the progress of shock therapy as well as the establishment and promoted application of arterial bypass grafting, thrombolytic therapy, percutaneous transluminal coronary angioplasty, extracorporeal circulation on cardiac surgery, cardiopulmonary resuscitation, limb replantation, and organ transplantation, blood reperfusion in multiple organs after ischemia has been achieved. However, the organs which undergo a period of ischemia appear to have the performance of damage aggravation. Objective: To summarize the research progress of MG53 protein in protecting five organs from ischemia/reperfusion injury, thereby providing reference for further in-depth study. METHODS: A computer-based online search of PubMed, Duxiu Knowledge Search and CNKI databases was performed for relevant literatures puldished between 1986 and 2016. The key words were “MG53, TRIM, Mitsugumin53, ischemic, reperfusion, preconditioning, postconditioning, RISK, membrane damage, Connexin43, KChIP2” in English and “MG53, ischemia/reperfusion” in Chinese. Finally 61 eligible articles were reviewed in accordance with the inclusion and exclusion criteria. Results and Conclusion: As a muscle-specific TRIM family protein, endogenous MG53 is involved in the repair of muscle cytomembrane damage, and the protective effects of ischemic preconditioning and postconditioning. Exogenous recombinant human MG 53 protein not only repairs membrane damage of various muscles and non-muscle cells, but also protects the myocardium, skeletal muscle, brain, lung and kidney from ischemia/reperfusion injury.",
keywords = "Blood vessels, Ischemia, Muscles, Organ transplantation, Tissue engineering",
author = "Liu, {Teng Fei} and Zhou, {Jian Kang} and Huang, {Tuan Jie} and Qu Xing and Kang Cheng and Peng Li and Li, {Dong Peng} and Bo Yang and Ma, {Shan Shan} and Fangxia Guan",
year = "2017",
month = "1",
day = "1",
doi = "10.3969/j.issn.2095-4344.2017.20.021",
language = "English (US)",
volume = "21",
pages = "3248--3254",
journal = "Chinese Journal of Tissue Engineering Research",
issn = "1673-8225",
publisher = "Journal of Clinical Rehabilitative Tissue Engineering Research",
number = "20",

}

TY - JOUR

T1 - Mg53 protein protects against multiorgan ischemia/reperfusion injury

T2 - Present and future

AU - Liu, Teng Fei

AU - Zhou, Jian Kang

AU - Huang, Tuan Jie

AU - Xing, Qu

AU - Cheng, Kang

AU - Li, Peng

AU - Li, Dong Peng

AU - Yang, Bo

AU - Ma, Shan Shan

AU - Guan, Fangxia

PY - 2017/1/1

Y1 - 2017/1/1

N2 - Background: In recent years, with the progress of shock therapy as well as the establishment and promoted application of arterial bypass grafting, thrombolytic therapy, percutaneous transluminal coronary angioplasty, extracorporeal circulation on cardiac surgery, cardiopulmonary resuscitation, limb replantation, and organ transplantation, blood reperfusion in multiple organs after ischemia has been achieved. However, the organs which undergo a period of ischemia appear to have the performance of damage aggravation. Objective: To summarize the research progress of MG53 protein in protecting five organs from ischemia/reperfusion injury, thereby providing reference for further in-depth study. METHODS: A computer-based online search of PubMed, Duxiu Knowledge Search and CNKI databases was performed for relevant literatures puldished between 1986 and 2016. The key words were “MG53, TRIM, Mitsugumin53, ischemic, reperfusion, preconditioning, postconditioning, RISK, membrane damage, Connexin43, KChIP2” in English and “MG53, ischemia/reperfusion” in Chinese. Finally 61 eligible articles were reviewed in accordance with the inclusion and exclusion criteria. Results and Conclusion: As a muscle-specific TRIM family protein, endogenous MG53 is involved in the repair of muscle cytomembrane damage, and the protective effects of ischemic preconditioning and postconditioning. Exogenous recombinant human MG 53 protein not only repairs membrane damage of various muscles and non-muscle cells, but also protects the myocardium, skeletal muscle, brain, lung and kidney from ischemia/reperfusion injury.

AB - Background: In recent years, with the progress of shock therapy as well as the establishment and promoted application of arterial bypass grafting, thrombolytic therapy, percutaneous transluminal coronary angioplasty, extracorporeal circulation on cardiac surgery, cardiopulmonary resuscitation, limb replantation, and organ transplantation, blood reperfusion in multiple organs after ischemia has been achieved. However, the organs which undergo a period of ischemia appear to have the performance of damage aggravation. Objective: To summarize the research progress of MG53 protein in protecting five organs from ischemia/reperfusion injury, thereby providing reference for further in-depth study. METHODS: A computer-based online search of PubMed, Duxiu Knowledge Search and CNKI databases was performed for relevant literatures puldished between 1986 and 2016. The key words were “MG53, TRIM, Mitsugumin53, ischemic, reperfusion, preconditioning, postconditioning, RISK, membrane damage, Connexin43, KChIP2” in English and “MG53, ischemia/reperfusion” in Chinese. Finally 61 eligible articles were reviewed in accordance with the inclusion and exclusion criteria. Results and Conclusion: As a muscle-specific TRIM family protein, endogenous MG53 is involved in the repair of muscle cytomembrane damage, and the protective effects of ischemic preconditioning and postconditioning. Exogenous recombinant human MG 53 protein not only repairs membrane damage of various muscles and non-muscle cells, but also protects the myocardium, skeletal muscle, brain, lung and kidney from ischemia/reperfusion injury.

KW - Blood vessels

KW - Ischemia

KW - Muscles

KW - Organ transplantation

KW - Tissue engineering

UR - http://www.scopus.com/inward/record.url?scp=85032035187&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85032035187&partnerID=8YFLogxK

U2 - 10.3969/j.issn.2095-4344.2017.20.021

DO - 10.3969/j.issn.2095-4344.2017.20.021

M3 - Article

AN - SCOPUS:85032035187

VL - 21

SP - 3248

EP - 3254

JO - Chinese Journal of Tissue Engineering Research

JF - Chinese Journal of Tissue Engineering Research

SN - 1673-8225

IS - 20

M1 - 2095-4344(2017)20-03248-07

ER -